Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001437749-24-029152
Filing Date
2024-09-13
Accepted
2024-09-13 16:15:24
Documents
3

Document Format Files

Seq Description Document Type Size
1 FORM DEFA14A mbrx20240905_defa14a.htm DEFA14A 9430
2 img01.jpg GRAPHIC 107914
3 img02.jpg GRAPHIC 112609
  Complete submission text file 0001437749-24-029152.txt   314282
Mailing Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007
Business Address 5300 MEMORIAL DRIVE SUITE 950 HOUSTON TX 77007 713-300-5160
Moleculin Biotech, Inc. (Filer) CIK: 0001659617 (see all company filings)

EIN.: 474671997 | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-37758 | Film No.: 241297918
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)